GRAYSLAKE, IL, March 12, 2013 (Press-News.org) Orthodontic treatment typically carries a significant price tag. For that reason, patients or parents of patients ought to feel confident in their choice of orthodontist, as well as the treatment plan.
When in doubt, get a second opinion.
Dr. Michael Stosich, an orthodontist in Grayslake who owns iDentity Orthodontics, frequently receives calls from people seeking a second opinion on treatment recommendations from another provider.
Stosich recommends getting a second opinion in these situations:
1- An orthodontist recommends emergency treatment.
"The need for emergency treatment is rare," Stosich says. "If you're being pressured to start treatment straight away, get another opinion."
2- An orthodontist recommends jaw surgery or tooth extraction.
"Surgery and extractions are serious decisions," says the Grayslake orthodontics expert. "Even if that's the proper course of action, I recommend getting another opinion just for peace of mind."
3- Lack of rapport between the patient and/or parent and the orthodontist.
Getting braces or some other form of orthodontic treatment requires a time commitment. A relationship will develop between the patient, parents and orthodontist. If a patient or parent doesn't "click" with the orthodontist, this could be a good sign to shop around.
"Find someone you like, and in whom you have confidence regarding their approach, experience and abilities," says Grayslake orthodontist, Stosich.
A Final Thought
Selecting a provider should be done with serious thought. Ask questions. Look at before/after photos of patients with similar malocclusions the orthodontist has treated.
Stosich's goal is to continuously provide effective treatment in an atmosphere that sets patients and parents at ease, and generates excitement toward their treatment, he says. Those who experience anything other than comfort and confidence in the orthodontist's skill and expertise should search until they find a professional with whom they can be happy.
Learn More:
To learn more about Dr. Michael Stosich or to schedule a complimentary consultation, call (847) 548-4200.
About Dr. Michael Stosich
Dr. Michael Stosich attended the Temple University School of Dentistry in Philadelphia and earned a Doctor of Dental Medicine degree. He then pursued critical specialty training in orthodontics and dentofacial orthopedics at Temple University, and also received a Master's Degree. He was awarded the Coben Scholar in Orthodontics. He went on to complete a four-year craniofacial fellowship at the University of Pennsylvania and The Children's Hospital of Philadelphia.
2013 Sinai Marketing and Dr. Michael Stosich. Authorization to post is granted, with the stipulation that Sinai Marketing and Dr. Michael Stosich are credited as sole source. Linking to other sites from this article is strictly prohibited, with the exception of herein imbedded links.
iDentity Orthodontics offers orthodontic care such as invisalign, adult braces and other orthodontic services in Illinois.
Dr. Michael Stosich, Grayslake Orthodontist Shares Reasons for a Second Opinion
There are some instances when a patient or parent of a patient will want to get a second orthodontic treatment opinion. Dr. Michael Stosich explains some of them.
2013-03-12
ELSE PRESS RELEASES FROM THIS DATE:
MobileSmith Partners with TVAR Solutions to Deliver Mobile Solutions to Federal Agencies
2013-03-12
MobileSmith, a leading provider of mobile software solutions for enterprise customers, and TVAR Solutions, a value-added reseller of cloud and mobile infrastructure to the US government, announced a strategic partnership to deliver innovative mobile solutions to Federal agencies.
"With TVAR's 20 years of experience delivering cloud IT solutions to the government, MobileSmith can now empower more Federal clients to quickly and cost-effectively build, deploy, and manage secure mobile applications for both iOS and Android devices," said Bob Dieterle, Senior VP ...
CyberlinkASP Completes SSAE 16 SOC 1 Audit Across Datacenter Footprint
2013-03-12
CyberlinkASP, the leader in hosted virtual desktop and private cloud solutions, today announced the completion of the company's annual SSAE 16 SOC 1 audit. CyberlinkASP enlisted an outside accounting firm and subjected itself to a rigorous third party review of all infrastructure, personnel, policies and procedures across its Dallas, Chicago and London facilities.
"This has been a major initiative for us the past few years as more and more firms require documented security policies and procedures relating to IT. We feel it's a must for anyone hosting or managing ...
Laura Wellington: "The Four-Star Diet" Sells Out on Amazon Leading to Invitations From "All-Star" Talk Shows
2013-03-12
No doubt, the media tour for the author of "The Four-Star Diet: Based Upon The Wisdom Of General Colin Powell & Other Ridiculously Brilliant Leaders" has only just begun. Explosive sales on Amazon and similar retailers have made it nearly impossible to get your hands on a print version of the book. With the demand continuing to rise to an already "sell out" crowd, Author Laura J. Wellington has received invitations to appear on numerous "Celebrity, Style, and News" shows from as far away as the UAE. She will begin to make those appearances ...
Rush scientists identify buphenyl as a possible drug for Alzheimer's disease
2013-03-11
(CHICAGO) – Buphenyl, an FDA-approved medication for hyperammonemia, may protect memory and prevent the progression of Alzheimer's disease.
Hyperammonemia is a life-threatening condition that can affect patients at any age. It is caused by abnormal, high levels of ammonia in the blood.
Studies in mice with Alzheimer's disease (AD) have shown that sodium phenylbutyrate, known as Buphenyl, successfully increases factors for neuronal growth and protects learning and memory, according to neurological researchers at the Rush University Medical Center.
Results from ...
Shock teams and ECMO save lives in massive STEMI
2013-03-11
MINNEAPOLIS, MN - March 9, 2013 - The use of extracorporeal membrane oxygenation (ECMO), accompanied by mechanical CPR, in patients with massive myocardial infarctions can lead to unexpected survival. These study findings are being presented March 9 at the American College of Cardiology Scientific Sessions.
ECMO is an advanced technology that functions as a replacement for a critically ill patient's heart and lungs. This is the first report of combined ECMO, mechanical CPR and therapeutic hypothermia (TH) use within a STEMI Network.
"For many patients who present with ...
Niacin therapy shows no benefits, has some harmful effects
2013-03-11
SAN FRANCISCO (March 9, 2013) — A highly anticipated study evaluating a combination of the vitamin niacin with the anti-flushing agent laropiprant finds the therapy provides no benefit to and may even be harmful for patients with vascular disease, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. Detailed trial data is presented here for the first time.
Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) is the largest-ever study of niacin, commonly used to raise ...
Drug protects against kidney injury from imaging dye in ACS patients
2013-03-11
SAN FRANCISCO (March 10, 2013) —High doses of a popular cholesterol-lowering drug significantly reduced the rate of acute kidney injury caused by dye used in imaging in acute coronary syndrome patients who underwent a coronary procedure, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session. This group of patients is at high risk for kidney damage related to contrast agents used in imaging tests.
Previous studies have demonstrated the kidney-protective value of various statins administered before patients undergo ...
Encouraging early results for redesigned Sapien valve
2013-03-11
SAN FRANCISCO (March 10, 2013) — The new Sapien XT aortic valve showed a non-significantly lower rate of death and strokes at 30 days than the original model, and both valves demonstrated notably better short-term outcomes than seen with the Sapien system in PARTNER I, according to the first results from the PARTNER II study presented today at the American College of Cardiology's 62nd Annual Scientific Session.
PARTNER II is the first randomized clinical trial involving the Sapien XT valve and the only one that compares the new device to the original FDA-approved Sapien ...
New biolimus stent equal to everolimus stent at 1 year
2013-03-11
SAN FRANCISCO (March 10, 2013) — In a match-up of Japan's top drug-releasing stent and a new device featuring a biodegradable coating, the newcomer delivered statistically comparable one-year results, according to data from the NEXT trial presented today at the American College of Cardiology's 62nd Annual Scientific Session.
Drug-eluting stents are structures placed inside narrowed coronary arteries to restore proper blood flow. A polymer coating on these devices slowly releases a drug designed to prevent restenosis—another blockage at the same site—and prevent a second ...
Fewer adverse events with 'double kissing' crush stent than culotte
2013-03-11
SAN FRANCISCO (March 10, 2013) — Patients with a type of coronary lesion linked with poor prognosis fared significantly better with the stent technique known as double kissing crush than with culotte stenting, according to data from the DKCRUSH-III trial presented today at the American College of Cardiology's 62nd Annual Scientific Session.
DKCRUSH-III is the first head-to-head comparison of double kissing (DK) crush and culotte stent techniques in coronary artery disease. The study focused on bifurcation lesions, which involve a main branch and a smaller side branch ...
LAST 30 PRESS RELEASES:
Cercus electric stimulation enables cockroach with trajectory control and spatial cognition training
Day-long conference addresses difficult to diagnose lung disease
First-ever cardiogenic shock academy features simulation lab
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
[Press-News.org] Dr. Michael Stosich, Grayslake Orthodontist Shares Reasons for a Second OpinionThere are some instances when a patient or parent of a patient will want to get a second orthodontic treatment opinion. Dr. Michael Stosich explains some of them.